299 related articles for article (PubMed ID: 35435358)
1. CD44 related stemness maneuvers oral squamous cell carcinoma biology.
Tandon A; Singh NN; Gulati N
Indian J Pathol Microbiol; 2022; 65(2):268-273. PubMed ID: 35435358
[TBL] [Abstract][Full Text] [Related]
2. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors.
Boxberg M; Götz C; Haidari S; Dorfner C; Jesinghaus M; Drecoll E; Boskov M; Wolff KD; Weichert W; Haller B; Kolk A
Histopathology; 2018 Oct; 73(4):559-572. PubMed ID: 29468726
[TBL] [Abstract][Full Text] [Related]
4. Prognostic evaluation of tumour budding in oral squamous cell carcinoma: Evidenced by CD44 expression as a cancer stem cell marker.
Niranjan KC; Raj M; Hallikeri K
Pathol Res Pract; 2023 Nov; 251():154883. PubMed ID: 37898041
[TBL] [Abstract][Full Text] [Related]
5. Preoperative assessment of CD44-mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma.
Morand GB; Ikenberg K; Vital DG; Cardona I; Moch H; Stoeckli SJ; Huber GF
Head Neck; 2019 Apr; 41(4):950-958. PubMed ID: 30561155
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
[TBL] [Abstract][Full Text] [Related]
7. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
[TBL] [Abstract][Full Text] [Related]
8. Lactic acid-induced M2-like macrophages facilitate tumor cell migration and invasion via the GPNMB/CD44 axis in oral squamous cell carcinoma.
Lin Y; Qi Y; Jiang M; Huang W; Li B
Int Immunopharmacol; 2023 Nov; 124(Pt B):110972. PubMed ID: 37806107
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of CD44 expression in oral squamous cell carcinoma: A meta-analysis.
Mirhashemi M; Sadeghi M; Ghazi N; Saghravanian N; Dehghani M; Aminian A
Ann Diagn Pathol; 2023 Dec; 67():152213. PubMed ID: 37856951
[TBL] [Abstract][Full Text] [Related]
10. Expression of p63 and CD44 in oral squamous cell carcinoma and correlation with clinicopathological parameters.
Saghravanian N; Anvari K; Ghazi N; Memar B; Shahsavari M; Aghaee MA
Arch Oral Biol; 2017 Oct; 82():160-165. PubMed ID: 28645102
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological correlation of stem cell markers expression in oral squamous cell carcinoma; relation to patients` outcome.
Hendawy H; Esmail AD; Zahani AMN; Elmahdi AH; Ibrahiem A
J Immunoassay Immunochem; 2021 Nov; 42(6):571-595. PubMed ID: 33896397
[No Abstract] [Full Text] [Related]
12. The emerging role of oral microbiota in oral cancer initiation, progression and stemness.
Saikia PJ; Pathak L; Mitra S; Das B
Front Immunol; 2023; 14():1198269. PubMed ID: 37954619
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
Dong C; Ye DX; Zhang WB; Pan HY; Zhang ZY; Zhang L
J Oral Pathol Med; 2015 May; 44(5):353-60. PubMed ID: 25482572
[TBL] [Abstract][Full Text] [Related]
14. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
[TBL] [Abstract][Full Text] [Related]
15. CD44 Sorted Cells Have an Augmented Potential for Proliferation, Epithelial-Mesenchymal Transition, Stemness, and a Predominantly Inflammatory Cytokine and Angiogenic Secretome.
Patil S
Curr Issues Mol Biol; 2021 Jun; 43(1):423-433. PubMed ID: 34205649
[TBL] [Abstract][Full Text] [Related]
16. Association of Stathmin (Op18) with TNM Staging and Grading of Oral Squamous Cell Carcinoma and Its Role in Tumor Progression.
Vadla P; Deepthi G; Julakanti V; Jahagirdar D; Meruva S; Tantravahi S
J Contemp Dent Pract; 2022 May; 23(5):497-502. PubMed ID: 35986456
[TBL] [Abstract][Full Text] [Related]
17. CD44+ cancer cell-induced metastasis: A feasible neck metastasis model.
Wu TF; Chen L; Bu LL; Gao J; Zhang WF; Jia J
Eur J Pharm Sci; 2017 Apr; 101():243-250. PubMed ID: 28215944
[TBL] [Abstract][Full Text] [Related]
18. CD44-positive cancer stem cells from oral squamous cell carcinoma exhibit reduced proliferation and stemness gene expression upon adipogenic induction.
Patil S; Al-Brakati A; Abidi NH; Almasri MA; Almeslet AS; Patil VR; Raj AT; Bhandi S
Med Oncol; 2022 Jan; 39(2):23. PubMed ID: 34982245
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.
Liu CM; Peng CY; Liao YW; Lu MY; Tsai ML; Yeh JC; Yu CH; Yu CC
J Formos Med Assoc; 2017 Jan; 116(1):41-48. PubMed ID: 26879838
[TBL] [Abstract][Full Text] [Related]
20. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
